Cue Biopharma, Inc. SEC filings CUE
Cue Biopharma, Inc. has 552 filings in SEC EDGAR's recent list, going back to Jun 19, 2015. Its latest annual report, Form ARS, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 21, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 21, 2026 | Sep 20, 2026 |
| EFFECT | Filing | Aug 20, 2026 | — |
| CORRESP | Letter to the SEC | Aug 18, 2026 | — |
| UPLOAD | Letter from the SEC | Aug 17, 2026 | — |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| S-3 | Shelf registration | Aug 12, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Aug 3, 2026 | Jul 27, 2026 |
| D | Filing | Jul 22, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
|
Jul 10, 2026 | Jul 9, 2026 |
| EFFECT | Filing | Jul 1, 2026 | — |
| CORRESP | Letter to the SEC | Jun 29, 2026 | — |
| UPLOAD | Letter from the SEC | Jun 25, 2026 | — |
| S-3 | Shelf registration | Jun 18, 2026 | — |
| EFFECT | Filing | Jun 17, 2026 | — |
| CORRESP | Letter to the SEC | Jun 15, 2026 | — |
| UPLOAD | Letter from the SEC | Jun 10, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 3, 2026 | Jun 1, 2026 |
| S-8 | Employee stock plan registration | Jun 3, 2026 | — |
| S-3 | Shelf registration | Jun 3, 2026 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Jun 2, 2026 | May 29, 2026 |
| DEF 14A | Proxy statement | May 21, 2026 | Jun 1, 2026 |
| 8-K | Current report | May 14, 2026 | May 14, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| D | Filing | May 14, 2026 | — |
| PRE 14A | Preliminary proxy statement | May 11, 2026 | Jun 1, 2026 |
| S-8 | Employee stock plan registration | May 1, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
|
May 1, 2026 | Apr 27, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Apr 22, 2026 | Apr 22, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Apr 13, 2026 | Apr 13, 2026 |
| 8-K |
Current report
Other events
|
Apr 7, 2026 | Apr 1, 2026 |
| EFFECT | Filing | Mar 31, 2026 | — |
| CORRESP | Letter to the SEC | Mar 27, 2026 | — |
| DEFA14A | Additional proxy material | Mar 27, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Mar 27, 2026 | Mar 23, 2026 |
| UPLOAD | Letter from the SEC | Mar 23, 2026 | — |
| S-3 | Shelf registration | Mar 16, 2026 | — |
| ARS | Annual report to shareholders | Mar 16, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Mar 16, 2026 | Mar 16, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2026 | Mar 16, 2026 |
| 10-K | Annual report | Mar 16, 2026 | Dec 31, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 6, 2026 | Mar 6, 2026 |
| 8-K |
Current report
Other events
|
Feb 18, 2026 | Feb 18, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 12, 2026 | Feb 9, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 19, 2025 | Dec 19, 2025 |
| 424B5 | Prospectus supplement | Dec 19, 2025 | — |
| 424B5 | Prospectus supplement | Dec 18, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 24, 2025 | Nov 24, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 20, 2025 | Nov 17, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 29, 2025 | Sep 26, 2025 |
| S-8 | Employee stock plan registration | Aug 12, 2025 | — |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Material agreement
|
Jul 1, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 10, 2025 | Jun 4, 2025 |
| DEFA14A | Additional proxy material | May 27, 2025 | — |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 3, 2025 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Apr 15, 2025 | Apr 14, 2025 |
| 424B5 | Prospectus supplement | Apr 15, 2025 | — |
| 424B5 | Prospectus supplement | Apr 14, 2025 | — |
| 8-K |
Current report
Material agreement
|
Apr 14, 2025 | Apr 10, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 14, 2025 | Apr 14, 2025 |
| S-8 | Employee stock plan registration | Mar 31, 2025 | — |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 12, 2025 | Mar 10, 2025 |
| UPLOAD | Letter from the SEC | Dec 16, 2024 | — |
| CORRESP | Letter to the SEC | Dec 11, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 5, 2024 | — |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Oct 8, 2024 | Oct 8, 2024 |
| 8-K |
Current report
Material agreement
|
Oct 4, 2024 | Oct 2, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 27, 2024 | Sep 26, 2024 |
| 424B5 | Prospectus supplement | Sep 27, 2024 | — |
| 424B5 | Prospectus supplement | Sep 26, 2024 | — |
| DEF 14A | Proxy statement | Sep 10, 2024 | Oct 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 3, 2024 | Aug 28, 2024 |
| PRE 14A | Preliminary proxy statement | Aug 28, 2024 | Oct 8, 2024 |
| 8-K |
Current report
Listing notice
|
Aug 16, 2024 | Aug 15, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 25, 2024 | Jul 24, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 7, 2024 | Jun 5, 2024 |
| DEFA14A | Additional proxy material | May 24, 2024 | — |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 5, 2024 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| S-8 | Employee stock plan registration | Mar 28, 2024 | — |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| 10-Q | Quarterly report | Nov 3, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 14, 2023 | Sep 12, 2023 |
| 10-Q | Quarterly report | Aug 8, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2023 | Jun 7, 2023 |
| EFFECT | Filing | May 26, 2023 | — |
| CORRESP | Letter to the SEC | May 24, 2023 | — |
| UPLOAD | Letter from the SEC | May 16, 2023 | — |
| S-3 | Shelf registration | May 9, 2023 | — |
| 10-Q | Quarterly report | May 9, 2023 | Mar 31, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 7, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 25, 2023 | Apr 19, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 12, 2023 | Apr 11, 2023 |
| S-8 | Employee stock plan registration | Mar 21, 2023 | — |
| 10-K | Annual report | Mar 21, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 10, 2023 | Mar 7, 2023 |
| 424B7 | Filing | Dec 30, 2022 | — |
| 424B3 | Prospectus | Dec 15, 2022 | — |
| EFFECT | Filing | Dec 14, 2022 | — |
| CORRESP | Letter to the SEC | Dec 12, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 9, 2022 | — |
| S-3 | Shelf registration | Dec 6, 2022 | — |
| D | Filing | Nov 21, 2022 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Nov 15, 2022 | Nov 14, 2022 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 4, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Officer or director change
|
Jun 22, 2022 | Jun 16, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2022 | Jun 9, 2022 |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| DEFA14A | Additional proxy material | Apr 29, 2022 | — |
| DEF 14A | Proxy statement | Apr 29, 2022 | Jun 9, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 30, 2022 | Mar 28, 2022 |
| S-8 | Employee stock plan registration | Mar 16, 2022 | — |
| 10-K | Annual report | Mar 16, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Material agreement, New debt
|
Feb 18, 2022 | Feb 15, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 15, 2021 | Nov 15, 2021 |
| 10-Q | Quarterly report | Nov 9, 2021 | Sep 30, 2021 |
| 424B5 | Prospectus supplement | Oct 1, 2021 | — |
| 8-K |
Current report
Material agreement, Other events
|
Oct 1, 2021 | Oct 1, 2021 |
| 424B5 | Prospectus supplement | Oct 1, 2021 | — |
| 10-Q | Quarterly report | Aug 9, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2021 | Jun 9, 2021 |
| EFFECT | Filing | May 21, 2021 | — |
| POS AM | Filing | May 21, 2021 | — |
| 10-Q | Quarterly report | May 10, 2021 | Mar 31, 2021 |
| DEFA14A | Additional proxy material | Apr 26, 2021 | — |
| DEF 14A | Proxy statement | Apr 26, 2021 | Jun 9, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 18, 2021 | Mar 18, 2021 |
| S-8 | Employee stock plan registration | Mar 9, 2021 | — |
| POS AM | Filing | Mar 9, 2021 | — |
| 10-K | Annual report | Mar 9, 2021 | Dec 31, 2020 |
| POSASR | Filing | Mar 9, 2021 | — |
| 8-K |
Current report
Material agreement
|
Nov 19, 2020 | Nov 18, 2020 |
| 10-Q | Quarterly report | Nov 9, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Officer or director change
|
Sep 17, 2020 | Sep 17, 2020 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Aug 24, 2020 | Aug 21, 2020 |
| 10-Q | Quarterly report | Aug 7, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jul 15, 2020 | Jul 9, 2020 |
| 8-K |
Current report
Material agreement
|
Jun 26, 2020 | Jun 24, 2020 |
| 8-K |
Current report
Material agreement
|
Jun 22, 2020 | Jun 22, 2020 |
| 424B5 | Prospectus supplement | Jun 22, 2020 | — |
| S-3ASR | Automatic shelf registration | Jun 22, 2020 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 5, 2020 | Jun 4, 2020 |
| DEFA14A | Additional proxy material | May 29, 2020 | — |
| DEF 14A | Proxy statement | May 29, 2020 | Jul 9, 2020 |
| 8-K |
Current report
Results of operations
|
May 19, 2020 | May 19, 2020 |
| PRE 14A | Preliminary proxy statement | May 15, 2020 | Jul 9, 2020 |
| 10-Q | Quarterly report | May 7, 2020 | Mar 31, 2020 |
| 10-K/A | Amended annual report | Apr 29, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Material agreement
|
Mar 27, 2020 | Mar 27, 2020 |
| 424B5 | Prospectus supplement | Mar 27, 2020 | — |
| 8-K |
Current report
Results of operations
|
Mar 17, 2020 | Mar 17, 2020 |
| S-8 | Employee stock plan registration | Mar 12, 2020 | — |
| 10-K/A | Amended annual report | Mar 12, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Mar 12, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 2, 2020 | Mar 2, 2020 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Feb 10, 2020 | Feb 9, 2020 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Nov 26, 2019 | Nov 22, 2019 |
| 424B5 | Prospectus supplement | Nov 25, 2019 | — |
| 8-K |
Current report
Results of operations
|
Nov 12, 2019 | Nov 12, 2019 |
| 10-Q | Quarterly report | Nov 7, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Officer or director change
|
Oct 9, 2019 | Oct 3, 2019 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Oct 7, 2019 | Oct 3, 2019 |
| 10-Q | Quarterly report | Aug 8, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Aug 6, 2019 | Aug 6, 2019 |
| UPLOAD | Letter from the SEC | Jul 31, 2019 | — |
| CORRESP | Letter to the SEC | Jul 9, 2019 | — |
| 10-Q/A | Amended quarterly report | Jul 9, 2019 | Mar 31, 2019 |
| 10-K/A | Amended annual report | Jul 9, 2019 | Dec 31, 2018 |
| UPLOAD | Letter from the SEC | Jul 3, 2019 | — |
| DEFA14A | Additional proxy material | Jun 18, 2019 | — |
| DEF 14A | Proxy statement | Jun 18, 2019 | Aug 6, 2019 |
| 8-K |
Current report
Material agreement
|
Jun 5, 2019 | Jun 5, 2019 |
| 424B5 | Prospectus supplement | Jun 5, 2019 | — |
| PRE 14A | Preliminary proxy statement | May 30, 2019 | Aug 6, 2019 |
| 10-Q | Quarterly report | May 8, 2019 | Mar 31, 2019 |
| 10-K/A | Amended annual report | Apr 30, 2019 | Dec 31, 2018 |
| S-8 | Employee stock plan registration | Mar 14, 2019 | — |
| 10-K | Annual report | Mar 14, 2019 | Dec 31, 2018 |
| CT ORDER | Filing | Feb 19, 2019 | — |
| 424B3 | Prospectus | Feb 8, 2019 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CUE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Somerville, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1645460
- Former names
- Imagen Biopharma, Inc. (until Jun 19, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.